Betta Pharmaceuticals Co., Ltd. (SHE: 300558)
China
· Delayed Price · Currency is CNY 47.39
-1.12 (-2.31%)
Nov 15, 2024, 3:04 PM CST
Betta Pharmaceuticals Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Nov '24 Nov 14, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 19,832 | 21,573 | 20,525 | 33,154 | 44,361 | 26,346 | Upgrade
|
| Market Cap Growth | -19.75% | 5.11% | -38.09% | -25.26% | 68.38% | 105.51% | Upgrade
|
| Enterprise Value | 21,433 | 23,045 | 20,899 | 31,905 | 43,858 | 26,465 | Upgrade
|
| Last Close Price | 47.39 | 51.32 | 48.98 | 78.91 | 105.81 | 64.63 | Upgrade
|
| PE Ratio | 43.51 | 61.83 | 140.14 | 85.77 | 71.01 | 113.39 | Upgrade
|
| Forward PE | 26.04 | 42.25 | 65.91 | 49.20 | 99.01 | 94.53 | Upgrade
|
| PS Ratio | 7.22 | 8.78 | 8.64 | 14.76 | 23.72 | 16.95 | Upgrade
|
| PB Ratio | 3.52 | 4.03 | 4.14 | 7.08 | 10.70 | 10.67 | Upgrade
|
| P/TBV Ratio | 5.59 | 7.45 | 6.38 | 11.18 | 14.20 | 17.03 | Upgrade
|
| P/FCF Ratio | 63.83 | - | - | - | - | - | Upgrade
|
| P/OCF Ratio | 16.23 | 23.60 | 66.91 | 62.95 | 68.67 | 47.46 | Upgrade
|
| PEG Ratio | 0.87 | 3.08 | 3.08 | 3.08 | 3.08 | 3.08 | Upgrade
|
| EV/Sales Ratio | 7.77 | 9.38 | 8.79 | 14.21 | 23.45 | 17.03 | Upgrade
|
| EV/EBITDA Ratio | 28.62 | 39.86 | 46.08 | 61.61 | 76.95 | 58.22 | Upgrade
|
| EV/EBIT Ratio | 52.72 | 82.34 | 100.98 | 91.48 | 105.73 | 84.88 | Upgrade
|
| EV/FCF Ratio | 68.98 | - | - | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.41 | 0.45 | 0.21 | 0.00 | 0.00 | 0.26 | Upgrade
|
| Debt / EBITDA Ratio | 3.11 | 4.17 | 2.27 | 0.02 | 0.00 | 1.42 | Upgrade
|
| Debt / FCF Ratio | 7.49 | - | - | - | - | - | Upgrade
|
| Asset Turnover | 0.30 | 0.29 | 0.34 | 0.39 | 0.40 | 0.41 | Upgrade
|
| Inventory Turnover | 1.56 | 1.16 | 0.81 | 0.72 | 0.86 | 0.75 | Upgrade
|
| Quick Ratio | 0.59 | 0.58 | 0.59 | 1.36 | 3.64 | 0.82 | Upgrade
|
| Current Ratio | 0.86 | 0.85 | 0.82 | 1.86 | 4.22 | 1.12 | Upgrade
|
| Return on Equity (ROE) | 8.03% | 6.47% | 2.59% | 8.60% | 18.18% | 9.67% | Upgrade
|
| Return on Assets (ROA) | 2.79% | 2.05% | 1.82% | 3.79% | 5.54% | 5.13% | Upgrade
|
| Return on Capital (ROIC) | 3.29% | 2.54% | 2.42% | 4.93% | 7.14% | 6.55% | Upgrade
|
| Earnings Yield | 2.30% | 1.61% | 0.71% | 1.16% | 1.37% | 0.88% | Upgrade
|
| FCF Yield | 1.57% | -0.84% | -3.43% | -0.70% | -0.09% | -0.25% | Upgrade
|
| Dividend Yield | 0.35% | 0.33% | 0.14% | 0.32% | 0.29% | 0.29% | Upgrade
|
| Payout Ratio | 31.34% | 31.69% | 95.94% | 35.93% | 19.74% | 41.05% | Upgrade
|
| Buyback Yield / Dilution | -0.53% | -1.10% | 0.02% | -2.32% | -1.09% | -1.35% | Upgrade
|
| Total Shareholder Return | -0.18% | -0.77% | 0.16% | -2.00% | -0.80% | -1.06% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.